Literature DB >> 29152503

Nomogram for survival analysis in the presence of competing risks.

Zhongheng Zhang1, Ronald B Geskus2,3, Michael W Kattan4, Haoyang Zhang5, Tongyu Liu6.   

Abstract

Clinical research usually involves time-to-event survival analysis, in which the presence of a competing event is prevalent. It is acceptable to use the conventional Cox proportional hazard regression to model cause-specific hazard. However, this cause-specific hazard cannot directly translate to the cumulative incidence function, and the latter is usually clinically relevant. The subdistribution hazard regression directly quantifies the impact of covariates on the cumulative incidence. When estimating the subdistribution hazard, subjects experiencing competing event continue to contribute to the risk set, and censoring weights are assigned to them after the competing event time. The weights are the conditional probability that a subject remains uncensored, and can be modelled to depend on the covariates of a subject. The first option to perform regression on the subdistribution hazard was the crr() function in the cmprsk package. However, it is not straightforward to draw a nomogram, which is a user-friendly tool for risk prediction, with the crr() function. To overcome this problem, we show an alternative method to use a nomogram function based on result of subdistribution hazard modeling.

Entities:  

Keywords:  Nomogram; competing risks; subdistribution; survival analysis

Year:  2017        PMID: 29152503      PMCID: PMC5673789          DOI: 10.21037/atm.2017.07.27

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  7 in total

1.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.

Authors:  Ronald B Geskus
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

3.  Simulating competing risks data in survival analysis.

Authors:  Jan Beyersmann; Aurélien Latouche; Anika Buchholz; Martin Schumacher
Journal:  Stat Med       Date:  2009-03-15       Impact factor: 2.373

4.  Survival analysis in the presence of competing risks.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2017-02

5.  Drawing Nomograms with R: applications to categorical outcome and survival data.

Authors:  Zhongheng Zhang; Michael W Kattan
Journal:  Ann Transl Med       Date:  2017-05

6.  A competing-risks nomogram for sarcoma-specific death following local recurrence.

Authors:  Michael W Kattan; Glenn Heller; Murray F Brennan
Journal:  Stat Med       Date:  2003-11-30       Impact factor: 2.373

7.  The importance of censoring in competing risks analysis of the subdistribution hazard.

Authors:  Mark W Donoghoe; Val Gebski
Journal:  BMC Med Res Methodol       Date:  2017-04-04       Impact factor: 4.615

  7 in total
  25 in total

1.  Overview of model validation for survival regression model with competing risks using melanoma study data.

Authors:  Zhongheng Zhang; Giuliana Cortese; Christophe Combescure; Roger Marshall; Minjung Lee; Hyun Ja Lim; Bernhard Haller
Journal:  Ann Transl Med       Date:  2018-08

2.  Transfers to Hemodialysis Among US Patients Initiating Renal Replacement Therapy With Peritoneal Dialysis.

Authors:  Rita L McGill; Daniel E Weiner; Robin Ruthazer; Dana C Miskulin; Klemens B Meyer; Eduardo Lacson
Journal:  Am J Kidney Dis       Date:  2019-07-10       Impact factor: 8.860

3.  Risk Factors of Relapse After Smoking Cessation: Results in China Family Panel Studies From 2010 to 2018.

Authors:  Naifan Hu; Zhenfan Yu; Yurun Du; Jiangping Li
Journal:  Front Public Health       Date:  2022-07-01

4.  Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.

Authors:  Fengshuo Xu; Jin Yang; Didi Han; Qiao Huang; Chengzhuo Li; Shuai Zheng; Hui Wang; Jun Lyu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.

Authors:  Fengshuo Xu; Xiaojie Feng; Fanfan Zhao; Qiao Huang; Didi Han; Chengzhuo Li; Shuai Zheng; Jun Lyu
Journal:  Cancer Med       Date:  2021-05-07       Impact factor: 4.452

6.  The first competing risk survival nomogram in patients with papillary renal cell carcinoma.

Authors:  Xing Su; Niu-Niu Hou; Li-Jun Yang; Peng-Xiao Li; Xiao-Jian Yang; Guang-Dong Hou; Xue-Lin Gao; Shuai-Jun Ma; Fan Guo; Rui Zhang; Wu-He Zhang; Wei-Jun Qin; Fu-Li Wang
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

7.  Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study.

Authors:  Felicia Baleanu; Michel Moreau; Alexia Charles; Laura Iconaru; Rafik Karmali; Murielle Surquin; Florence Benoit; Aude Mugisha; Marianne Paesmans; Michel Rubinstein; Serge Rozenberg; Pierre Bergmann; Jean-Jacques Body
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

8.  Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.

Authors:  Yan-Bo Xu; Hong Liu; Qi-Hua Cao; Jia-Li Ji; Rong-Rong Dong; Dong Xu
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

9.  Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.

Authors:  Lipin Liu; Qiuzi Zhong; Ting Zhao; Dazhi Chen; Yonggang Xu; Gaofeng Li
Journal:  Radiat Oncol       Date:  2021-06-10       Impact factor: 3.481

10.  Preoperative Predictors of Lymph Node Metastasis in Colon Cancer.

Authors:  Yansong Xu; Yi Chen; Chenyan Long; Huage Zhong; Fangfang Liang; Ling-Xu Huang; Chuanyi Wei; Shaolong Lu; Weizhong Tang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.